GE HealthCare Technologies Inc [GEHC] stock is trading at $71.02, up 0.55%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GEHC shares have lost -3.26% over the last week, with a monthly amount drifted -5.91%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GE HealthCare Technologies Inc [NASDAQ: GEHC] stock has seen the most recent analyst activity on October 13, 2025, when Barclays initiated its Equal Weight rating and assigned the stock a price target of $86. Previously, Citigroup downgraded its rating to Neutral on October 07, 2025, and kept the price target unchanged to $83. On May 05, 2025, upgrade upgraded it’s rating to Neutral but maintained its price target of $73 on the stock. Goldman upgraded its rating to a Buy and increased its price target to $100 on March 11, 2025. Jefferies upgraded its rating to a Buy and raised its price target to $103 on January 08, 2025. UBS downgraded its rating to Sell for this stock on September 26, 2024, and downed its price target to $74. In a note dated September 18, 2024, BTIG Research upgraded a Buy rating on this stock but restated the target price of $100.
GE HealthCare Technologies Inc [GEHC] stock has fluctuated between $57.65 and $94.80 over the past year. Currently, Wall Street analysts expect the stock to reach $83.5 within the next 12 months. GE HealthCare Technologies Inc [NASDAQ: GEHC] shares were valued at $71.02 at the most recent close of the market. An investor can expect a potential return of 17.57% based on the average GEHC price forecast.
Analyzing the GEHC fundamentals
GE HealthCare Technologies Inc [NASDAQ:GEHC] reported sales of 20.25B for the trailing twelve months, which represents a growth of 5.76%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.24 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 70.20 points at the first support level, and at 69.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 71.67, and for the 2nd resistance point, it is at 72.33.
Ratios To Look Out For
For context, GE HealthCare Technologies Inc’s Current Ratio is 1.14. Also, the Quick Ratio is 0.91, while the Cash Ratio stands at 0.4. Considering the valuation of this stock, the price to sales ratio is 1.60, the price to book ratio is 3.24 and price to earnings (TTM) ratio is 14.68.
Transactions by insiders
Recent insider trading involved Kenneth Stacherski, Former Officer, that happened on Oct 27 ’25 when 4585.0 shares were purchased. Former Officer, Kenneth Stacherski completed a deal on Sep 22 ’25 to buy 19524.0 shares. Meanwhile, Former Officer Kenneth Stacherski bought 11757.0 shares on Sep 12 ’25.
